GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (NAS:IMCC) » Definitions » Gross Profit

IMCC (IM Cannabis) Gross Profit : $6.14 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is IM Cannabis Gross Profit?

IM Cannabis's gross profit for the three months ended in Dec. 2024 was $1.88 Mil. IM Cannabis's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $6.14 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. IM Cannabis's gross profit for the three months ended in Dec. 2024 was $1.88 Mil. IM Cannabis's Revenue for the three months ended in Dec. 2024 was $9.36 Mil. Therefore, IM Cannabis's Gross Margin % for the quarter that ended in Dec. 2024 was 20.10%.

IM Cannabis had a gross margin of 20.10% for the quarter that ended in Dec. 2024 => Competition eroding margins

During the past 13 years, the highest Gross Margin % of IM Cannabis was 65.88%. The lowest was 15.64%. And the median was 18.60%.


IM Cannabis Gross Profit Historical Data

The historical data trend for IM Cannabis's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Gross Profit Chart

IM Cannabis Annual Data
Trend Apr14 Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.17 4.95 6.74 7.34 5.93

IM Cannabis Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 1.31 0.62 2.32 1.88

Competitive Comparison of IM Cannabis's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, IM Cannabis's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IM Cannabis's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IM Cannabis's Gross Profit distribution charts can be found below:

* The bar in red indicates where IM Cannabis's Gross Profit falls into.


;
;

IM Cannabis Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

IM Cannabis's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=37.924 - 31.992
=5.93

IM Cannabis's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=9.36 - 7.479
=1.88

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.14 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

IM Cannabis's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=1.88 / 9.36
=20.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


IM Cannabis  (NAS:IMCC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

IM Cannabis had a gross margin of 20.10% for the quarter that ended in Dec. 2024 => Competition eroding margins


IM Cannabis Gross Profit Related Terms

Thank you for viewing the detailed overview of IM Cannabis's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


IM Cannabis Business Description

Traded in Other Exchanges
Address
Central District, Kibbutz Glil Yam, ISR, 4690500
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.